Phage Therapy against <em>Staphylococcus aureus</em>: Selection and Optimization of Production Protocols of Novel Broad-Spectrum <em>Silviavirus</em> Phages

<b>Background:</b> Phage therapy a promising antimicrobial strategy to address antimicrobial resistance for infections caused by the major human pathogen <i>Staphylococcus aureus</i>. Development of therapeutic phages for human use should follow pharmaceutical standards, including selection of stric...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Camille Kolenda, Mathieu Medina, Mélanie Bonhomme, Floriane Laumay, Tiphaine Roussel-Gaillard, Patricia Martins-Simoes, Anne Tristan, Fabrice Pirot, Tristan Ferry, Frédéric Laurent, PHAGEinLYON Study Group
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2022-09-01
Sarja:	Pharmaceutics
Aiheet:	bacteriophages phages phage therapy <i>Staphylococcus</i> production yield
Linkit:	https://www.mdpi.com/1999-4923/14/9/1885
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!